Open access peer-reviewed chapter - ONLINE FIRST

Phyto-Nanoparticles in Osteogenesis

Written By

Nandita Suresh, Betsy Joseph, Tuomas Waltimo and Sukumaran Anil

Submitted: 04 March 2024 Reviewed: 05 March 2024 Published: 20 June 2024

DOI: 10.5772/intechopen.1005422

Innovation in Osteogenesis Research IntechOpen
Innovation in Osteogenesis Research Edited by Ziyad S. Haidar

From the Edited Volume

Innovation in Osteogenesis Research [Working Title]

Prof. Ziyad S. Haidar

Chapter metrics overview

10 Chapter Downloads

View Full Metrics

Abstract

Phyto-nanoparticles derived from plants are an emerging class of nanomaterials that integrate the versatility of nanotechnology with the therapeutic potential of botanical ingredients. This chapter explores the utility of phyto-nanoparticles in stimulating osteogenesis for applications in bone tissue engineering and regeneration. Plant extracts serve as sustainable nanoparticle building blocks or coatings through green synthesis approaches. Resultant phyto-nanoparticles possess multifunctional capabilities stemming from the bioactive phytochemical components that enable the modulation of osteogenic cells like mesenchymal stem cells and osteoblasts. Diverse phyto-nanoparticles based on green tea, aloe vera, curcumin, and other plant derivatives have demonstrated the ability to enhance osteoblast differentiation, proliferation, and mineralized matrix deposition. Proposed mechanisms encompass direct cell interactions, sustained intracellular delivery of osteogenic drugs, and complementary anti-inflammatory effects. Capitalizing on these osteogenic properties, researchers have designed innovative tissue engineering scaffolds, functionalized bone implants, and developed therapeutic carriers for diseases like osteoporosis using phyto-nanotechnology. Further innovations in fabrication strategies and integration with emerging technologies will realize smarter, personalized plant-based nanosystems to advance bone regeneration capabilities dramatically.

Keywords

  • phyto-nanoparticles
  • osteogenesis
  • bone tissue engineering
  • green synthesis
  • mesenchymal stem cells

1. Introduction

Nanotechnology is a boundless frontier where science and engineering merge to revolutionize the manipulation and fabrication of materials and devices on a minuscule scale, a billionth of a meter [1]. One prominent arena in which it has permeated is medicine, giving rise to nanomedicine, which has endless possibilities in diagnostics, drug delivery, bone, and tissue regeneration. Nanomedicine utilizes the advancement, composition, assessment, and utilization of nano-sized materials and devices to detect and treat various illnesses—from cancer to heart disease to neurological disorders [2]. Nanoparticles can interact specifically with cells and tissues at the molecular level to provide accurate, potent, and long-lasting diagnoses and therapies.

Bone has an innate capacity to regenerate following trauma or disease. However, this self-healing ability is limited to minor defects and often fails for critical segmental losses arising from fracture nonunion, tumor resections, and skeletal abnormalities. Osteogenesis mediated by osteogenic cells drives bone healing and regeneration [3]. Mesenchymal stem cells (MSCs) stimulated by osteoinductive signals can differentiate into osteoblasts, representing the critical bone-forming cell population. Osteoblasts produce extracellular matrix proteins like collagen I and osteocalcin, constituting the organic matrix. Calcium deposition then forms mineralization and complex tissue formation [4]. Incorporating osteogenic cells with supportive biomaterial scaffolds enables engineered bone graft substitutes that integrate seamlessly with host vasculature and tissues after implantation. Beyond functioning as mechanical supports, biomaterial matrices provide biophysical and biochemical cues that direct survival, proliferation, and differentiation [5]. However, clinical translation needs to be improved by non-optimal scaffold properties, leading to poor cell integration and vascularization. There is tremendous scope for novel nanotechnology solutions to address these limitations in scaffold design [6]. Studies have shown that various nanoparticles, including hydroxyapatite, metallic, and rare earth nanoparticles, can support bone growth and enhance the osteogenic differentiation of mesenchymal stem cells [7]. Additionally, researchers have been investigating nanocomposite scaffolds, nanofibers, and nanoparticle-modified polymeric materials to improve tissue engineering scaffolds’ physical and chemical properties, ultimately improving osteogenesis [8].

Phyto-nanoparticles are an emerging class of nanoparticles synthesized from bioactive phytochemical (plant-derived) compounds. Ranging from 1 to 100 nm in size, these plant-inspired nanomaterials integrate the physicochemical versatility of nanoscale materials with the vast compositional diversity and therapeutic utility of botanical ingredients [9]. Phyto-nanoparticles encompass nanomaterials derived from edible and medicinal plants, including herbs, fruit and vegetable crop produce, and general botanicals. Phytochemicals are the primary building blocks or functionalizing coatings for engineering nanoparticle architectures through bottom-up self-assembly and surface modification strategies [10].

Advertisement

2. Materials and methods: Literature review and reference selection

This chapter on “Phyto-Nanoparticles in Osteogenesis” was meticulously assembled through a comprehensive literature review using various scientific databases, including PubMed, Scopus, and Web of Science. Search terms used involved combinations of keywords such as “phyto-nanoparticles,” “osteogenesis,” “bone regeneration,” “green synthesis,” and “plant extracts.” The initial search produced a substantial number of research articles, which were subsequently screened for relevance, with a preference for studies published within the last 5 to 10 years to ensure the inclusion of the latest research developments. Additionally, significant consideration was given to the impact factor of the journals to prioritize high-quality, peer-reviewed sources such as original research articles, review papers, and book chapters. The selected references were thoroughly examined to extract critical data concerning the types of phyto-nanoparticles, their synthesis methods, mechanisms of action, and applications in bone tissue engineering and regeneration. The chapter is structured to offer a detailed overview of the subject, beginning with an introduction to phyto-nanoparticles and their benefits. This is followed by an in-depth discussion on various phyto-nanoparticles, detailing their synthesis, properties, and roles in bone regeneration. References are meticulously integrated throughout the chapter to bolster the information presented and guide readers to further detailed resources for expanded research.

Advertisement

3. Phyto-nanoparticles

Phyto-nanoparticles, synthesized from plant extracts, have garnered considerable attention for their distinctive properties and wide range of potential uses in fields such as medicine, agriculture, and food production. These nanoparticles are environmentally friendly and cost-effective, and their scalability adds to their appeal as a method for synthesizing metal and metal oxide nanoparticles [11]. A multitude of methods are utilized for their synthesis. One such method is phytosynthesis, where plant extracts are employed as both environmentally friendly reducing and capping agents to create metal oxide nanoparticles [12]. Another approach is green synthesis, which harnesses plant extracts, fungi, and algae biomolecules to produce nanoparticles. Biogenic synthesis is highly regarded for its environmentally friendly nature, cost-effectiveness, and potential for easy scalability [9, 13]. Another approach to producing nanoparticles is through seed-mediated synthesis, which utilizes plant seeds. For instance, nanoparticles have successfully been synthesized using fenugreek seed extract [14]. Additionally, the Microwave-assisted method leverages microwave technology to expedite the synthesis of nanoparticles using plant extracts [15]. Ultrasonication involves accelerating nanoparticle synthesis using plant extracts [16]. The FDA has classified plant-based nanoparticles as generally recognized as safe (GRAS) and biodegradable, making them superior to other nanoparticle options for several reasons. They have lower toxicity levels and possess beneficial qualities such as greater energy efficiency and antioxidant, antifungal, antibacterial, and anticancer properties. The use of plant extracts to produce these nanoparticles is believed to contribute to these advantageous properties [17].

3.1 Phyto-nanoparticles in biomedical applications

Phyto-nanoparticles are derived from various plant sources and offer potential drug delivery, imaging, and therapy applications. One of the primary advantages of Phyto-nanoparticles is their biocompatibility and low toxicity compared to synthetic nanoparticles [18]. Plant-based nanoparticles are naturally derived and have a lower risk of causing adverse reactions in the human body. They are also biodegradable, which means they can be easily eliminated from the body after serving their purpose. This makes them an attractive alternative to conventional nanoparticles, which may have potential long-term toxicity concerns. Phyto-nanoparticles can be synthesized from various plant sources, including leaves, fruits, seeds, and roots. The synthesis process typically involves the extraction of plant compounds, followed by reducing and stabilizing metal ions to form nanoparticles [19]. Green synthesis methods, such as using plant extracts as reducing and capping agents, have gained popularity due to their simplicity, cost-effectiveness, and environmental friendliness.

One of the most promising applications of Phyto-nanoparticles in biomedicine is drug delivery (Figure 1). Plant-based nanoparticles can be engineered to encapsulate and deliver drugs to specific target sites in the body, improving therapeutic efficacy and reducing side effects [20]. Curcumin, a natural compound found in turmeric, has been encapsulated in phyto-nanoparticles derived from various plant sources, such as ginger and aloe vera. These nanoformulations have shown enhanced bioavailability, stability, and targeted delivery of curcumin to cancer cells, demonstrating their potential in cancer therapy [21].

Figure 1.

Biomedical applications of phyto-nanoparticles.

In addition to drug delivery, phyto-nanoparticles have also been explored for their potential in imaging and diagnosis. Nanoparticles derived from plants such as tea, grapes, and pomegranate have been found to exhibit fluorescent properties, making them suitable for bioimaging applications [22]. These nanoparticles can be functionalized by targeting ligands to label and image diseased cells or tissues, aiding in the early detection and diagnosis of diseases such as cancer. Moreover, phyto-nanoparticles have shown promise in wound healing and tissue regeneration. Plant-based nanoparticles, such as those derived from aloe vera and ginger, have been found to possess antimicrobial and anti-inflammatory properties [23]. When incorporated into wound dressings or scaffolds, these nanoparticles can promote faster wound healing, reduce the risk of infection, and stimulate tissue regeneration.

Phyto-nanoparticlesare promising in biomedical applications due to their biocompatibility, low toxicity, and versatile properties. With their potential in drug delivery, imaging, and therapy, plant-based nanoparticles offer a sustainable and effective alternative to conventional nanoparticles. As research in this field advances, Phyto-nanoparticles are expected to play an increasingly important role in developing novel biomedical technologies for diagnosing and treating various diseases.

3.2 Advantages of plant-based nanoparticles

The growing utilization of plant sources for nanoparticle fabrication is motivated by their unique advantages:

3.2.1 Sustainability

Using plant sources for nanoparticle fabrication offers a more sustainable and environmentally friendly approach than conventional processes. By avoiding toxic chemicals, phyto-nanoparticle synthesis minimizes the negative environmental impact associated with traditional nanoparticle production. This green approach reduces the generation of hazardous waste and the consumption of non-renewable resources. Using plant-based materials also contributes to the renewable nature of phyto-nanoparticle synthesis, as plants can be cultivated and harvested sustainably, ensuring a continuous supply of raw materials without depleting natural resources. Furthermore, the biodegradability of plant-derived nanoparticles reduces the risk of long-term accumulation in the environment, mitigating potential ecological concerns. Overall, the sustainability advantages of plant-based nanoparticle fabrication align with the growing global emphasis on green chemistry and sustainable manufacturing practices, making it an attractive approach for developing eco-friendly nanomaterials [24].

3.2.2 Biocompatibility

The inherent biocompatibility of plant-based nanoparticles is a significant advantage that facilitates their application in biomedical fields. Plants have evolved to produce a wide range of biomolecules that are intrinsically compatible with human physiology, as many of these compounds are naturally present in our diets. When nanoparticles are synthesized using plant extracts, the biocompatibility of the plant components is transferred to the resulting nanomaterials. Plant-derived biomolecules on the surface of the nanoparticles can also enhance their interaction with cells and tissues, promoting better integration and reducing the likelihood of immune rejection. Moreover, the biodegradability of plant-based nanoparticles ensures that they can be safely metabolized and eliminated from the body after serving their therapeutic purpose, minimizing the potential for long-term accumulation and associated health risks [25]. The biocompatibility of phyto-nanoparticles is particularly advantageous for applications such as drug delivery, tissue engineering, and wound healing, where the nanomaterials are intended to interact closely with living systems. By leveraging the inherent biocompatibility of plant-derived materials, researchers can develop safer and more effective nanomedicines and biomedical devices.

3.2.3 Multifunctionality

One of the critical advantages of plant-based nanoparticles is their multifunctionality, which arises from the diverse range of phytochemicals present in plant extracts. Plants produce many bioactive compounds, including polyphenols, flavonoids, alkaloids, and terpenoids, each with unique therapeutic properties. When these phytochemicals are incorporated into nanoparticles, they impart additional functionalities beyond the basic properties of the nanomaterial itself. Furthermore, encapsulating phytochemicals into nanoparticles can improve their stability, protecting them from degradation and enabling controlled release over an extended period. This enhanced stability and sustained release profile can significantly improve encapsulated compounds’ bioavailability and therapeutic efficacy [26]. The multifunctional nature of phyto-nanoparticles opens up exciting opportunities for developing targeted therapies and multifaceted approaches to address complex medical challenges.

3.2.4 Scalability

The scalability of plant-based nanoparticle production is another significant advantage that makes it an attractive approach for large-scale manufacturing. Plants can be easily cultivated and harvested in large quantities through well-established agricultural practices, providing an abundant and renewable source of raw materials for nanoparticle synthesis. This scalability is crucial for meeting the increasing demand for nanomaterials in various industrial and biomedical applications. Compared to other methods of nanoparticle production, such as chemical synthesis or microbial fermentation, plant-based approaches offer the potential for higher yields and more cost-effective production. Advances in bioengineering and molecular pharming techniques can further enhance the scalability of phyto-nanoparticle production. For example, genetic engineering can develop transgenic plants that overexpress specific phytochemicals of interest, leading to higher yields of the desired compounds. Similarly, optimization of plant growth conditions and extraction processes can improve the efficiency and productivity of nanoparticle synthesis. The ability to scale up plant-based nanoparticle production is particularly relevant for applications that require large quantities of nanomaterials, such as environmental remediation, agricultural interventions, and industrial catalysis. The scalability of phyto-nanoparticle production and the sustainability and cost-effectiveness of plant-based approaches make it a promising avenue for commercially developing nanomaterials.

These integral advantages underpin the promise of plant-based nanoparticle systems to provide sustainable, therapeutic alternatives to conventional nanomaterials. Phyto-nanoparticles constitute a versatile platform to harness the functional benefits of nanotechnology for human healthcare applications [27].

3.3 Disadvantages and limitations of phyto-nanoparticles

Phyto-nanoparticles, synthesized primarily through green synthesis methods using plant extracts, represent a novel class of nanomaterials that combine nanoparticles’ physicochemical properties with plants’ biological attributes. Despite their burgeoning application in the biomedical field, several significant limitations and disadvantages persist, impacting their practical utility and efficacy. One primary concern with phyto-nanoparticles is their complex and often inconsistent synthesis process. While green synthesis is touted for its environmental friendliness, the lack of control over the nanoparticles’ size, shape, and dispersity can result in varied functional properties. This heterogeneity can adversely affect the reproducibility of experimental results and the scalability of production processes [28]. The biological pathways involved in synthesizing phyto-nanoparticles depend heavily on the type of plant extract used, which can introduce variability due to differences in the plants’ concentration and composition of bioactive compounds. These variations make standardizing practices and achieving consistent nanoparticle traits challenging and critical for specific applications, particularly in drug delivery and therapeutic roles.

Moreover, the long-term stability and storage of phyto-nanoparticles pose another significant challenge. Nanoparticles derived from plant sources may be prone to aggregation or degradation over time, diminishing their effectiveness and shelf life. Environmental factors such as temperature, light, and humidity can further exacerbate these stability issues, necessitating sophisticated and often expensive storage solutions to maintain their functional integrity over time [29]. The safety and biocompatibility of phyto-nanoparticles, although generally favorable compared to synthetic nanoparticles, remain areas of concern. The interaction of phyto-nanoparticles with cells and biological systems can sometimes induce cytotoxic effects, particularly at higher concentrations or prolonged exposure. The presence of residual plant materials or contaminants from the synthesis process can also provoke immune responses or inflammatory reactions, which are detrimental in biomedical applications. Additionally, the metabolic pathways involved in degrading and eliminating these nanoparticles from the body are poorly understood, raising concerns about potential bioaccumulation and toxicity [30].

Regulatory challenges also constitute a significant disadvantage. The nanoparticle approval process is stringent and complex, particularly in food and medicine. Phyto-nanoparticles, due to their novel nature, face numerous hurdles in gaining regulatory approval across different jurisdictions. The lack of standardized characterization methods for these nanoparticles further complicates their assessment, requiring extensive and comprehensive studies to establish their safety profiles and therapeutic efficacy. From an application perspective, while phyto-nanoparticles are explored for their potential in various therapeutic and diagnostic roles, their real-world applications are limited by the current understanding of their interactions at the molecular, cellular, and systemic levels. Incomplete knowledge about the mechanisms these nanoparticles exert their effects can limit their design and functional optimization for specific applications. For instance, in drug delivery, the unpredictable release profiles and interaction with biological membranes can result in suboptimal therapeutic outcomes. While phyto-nanoparticles offer several promising advantages, their practical application is hindered by significant limitations related to synthesis variability, stability, safety, regulatory challenges, and incomplete understanding of their biological interactions [31]. Addressing these challenges requires coordinated research efforts to standardize synthesis methods, establish robust safety evaluations, and enhance the functional properties of these nanomaterials for reliable and practical use across various domains.

Advertisement

4. Types of phyto-nanoparticles in osteogenesis

A vast library of plants encompassing food crops, herbs, and their molecular constituents have been transformed into nanocarriers and nanostructures for stimulating stem cell osteogenesis (Figure 2). The rich phytochemical reservoirs serve as building elements for nanoparticle synthesis and confer biofunctional outputs [32]. When appropriately engineered into nanosystems, unique properties emerge from the crosstalk between physicochemical and biological cues that effectively direct bone healing.

Figure 2.

Diverse plant sources for deriving phyto-nanoparticles with osteogenic potential. Phyto-nanoparticles synthesized from various botanical ingredients, including green tea, aloe vera, curcumin, licorice, flavonoids, silymarin, and ginseng, have shown the ability to stimulate osteoblast activity and bone formation. The rich phytochemical composition of these plant sources confers biofunctional properties to the engineered nanoparticles for directing stem cell differentiation and modulating bone cell fates toward enhanced osteogenesis.

4.1 Green tea extract nanoparticles

Green tea, derived from the leaves of the Camellia sinensis plant, has been identified for its numerous benefits. Its high concentration of polyphenolic compounds, specifically catechins, contributes to its antioxidant, anti-inflammatory, and osteogenic activity [33]. Research has proven that tea extract provides considerable safety in preventing neurodegenerative diseases, including Parkinson’s and Alzheimer’s [34]. Additionally, green tea has displayed anti-diabetic properties in animal models [35]. Its antibacterial, anti-HIV, anti-aging, and anti-inflammatory activities have also been documented.

Green tea extract nanoparticles (GTE-NPs) have been shown to have anti-inflammatory effects in animal models. Inflammation is a critical protective mechanism in the healing process. Still, it can also cause pain and swelling associated with pro-inflammatory cytokines such as interleukin (IL) IL-1, IL-6, and tissue necrosis factor-alpha (TNF-α) [36]. GTE-NPs can improve mice’s physiological motor and cognitive function during inflammation, indicating their potential therapeutic applications. They also have antioxidant properties, which can help protect cells from oxidative stress and promote tissue regeneration [33].

GTE-NPs offer potential benefits in bone regeneration due to their unique properties, including antioxidant, anti-inflammatory, and osteogenic effects. Green tea has been reported to promote tissue remodeling and bone healing, making it a promising candidate for enhancing bone regeneration [36]. The catechin (−)-epigallocatechin-3-gallate (EGCG) in green tea facilitates fracture healing and increases bone mineral density, indicating its potential to improve bone health [37]. EGCG enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells through the Wnt signaling pathway, which controls bone development. Additionally, green tea catechins enhance osteogenesis in bone marrow mesenchymal stem cells [38]. Animal experiments have indicated that green tea extract EGCG can significantly stimulate bone regeneration in rat skull defects [39]. Furthermore, GTE-NPs combined with hydroxyapatite create composite materials that exhibit favorable bone regeneration abilities [40]. Potential mechanisms of GTE-NPs in promoting osteogenesis include activation of the Wnt pathway, osteogenic differentiation enhancement, and bone regeneration stimulation [41]. Further research is needed to understand the mechanisms of GTE-NPs in osteogenesis fully, but current findings suggest their potential therapeutic applications for bone regeneration and tissue engineering.

4.2 Aloe vera-based nanoparticles

Aloe vera, a succulent plant species, has been widely recognized for its diverse medicinal applications. The use of aloe vera dates back thousands of years, and its therapeutic properties have been extensively studied. Aloe vera is commonly used topically to treat various skin conditions, including burns, cuts, insect bites, and eczemas, owing to its anti-inflammatory, antimicrobial, and wound-healing properties [42]. Additionally, aloe vera has been investigated as a dietary supplement, with studies suggesting benefits such as reduced dental plaque, accelerated wound healing, and potential glycemic control [43]. Furthermore, oral aloe vera gel has been associated with lowering blood glucose and cholesterol levels, making it attractive for managing diabetes and hyperlipidemia [44]. The plant’s unique properties have also led to research on its potential as a cytotoxic, antitumoral, anticancer, and anti-diabetic agent.

Aloe vera promotes wound healing at the cellular and subcellular levels. It accelerates wound healing by stimulating the proliferation and migration of fibroblasts and keratinocytes, which are essential for repairing injured tissues [45]. Aloe vera nanoparticles (AVNPs) are a recent development in nanotechnology and have gained attention due to their potential biomedical applications. AVNPs have exhibited the potential to promote osteogenesis owing to their unique antioxidant, anti-inflammatory, and osteogenic effects [46]. Gold nanoparticles (AuNPs) synthesized using aloe vera possess osteoinductive properties crucial for bone formation. Using aloe vera in AuNP synthesis provides an eco-friendly and cost-effective approach.

Electrophoretic Deposition of aloe vera-chitosan-hydroxyapatite nanocomposite coatings onto titanium implants was studied [47]. Chitosan was the binding agent, while hydroxyapatite facilitated osseointegration with surrounding bone. Aloe vera particles conferred antibacterial effects against common pathogens like S. aureus, responsible for many implant-associated infections. Excellent biocompatibility was verified by the growth and ALP activity of cultured osteosarcoma cells, making this nanocomposite coating ideal for enhancing the functionality of titanium bone implants. Beyond direct osteogenic stimulation, aloe vera nanoparticles can also play auxiliary roles, such as anti-scarring during bone healing [48]. Aloe vera nanoparticles into a putty containing bioactive glass ceramics and applied as a protective barrier membrane over bone defects. The released aloe vera phytochemicals were found to inhibit myofibroblast differentiation and activity of human dermal fibroblasts via TGF-β1 modulation, thus reducing scar tissue formation while permitting unimpeded bone formation across the defect.

4.3 Curcumin nanoparticles

Curcumin is a chemical compound found in the Curcuma longa plant, also known as turmeric. It is a popular condiment with antioxidant, anti-inflammatory, antimicrobial, and anticancer properties, and it has been widely used in indigenous and traditional medicine [27]. Research suggests that curcumin may help manage oxidative stress, inflammation, metabolic syndrome, arthritis, anxiety, and degenerative eye diseases [49].

In vitro and in vivo studies have demonstrated anti-inflammatory, anti-diabetic, anti-proliferative, and pro-apoptotic effects against various tumors [50]. Curcumin has also exhibited potential against Alzheimer’s, multiple sclerosis, rheumatoid arthritis, atherosclerosis, cataracts, liver damage, lung toxicity, fibrosis, bleeding, clotting, platelet aggregation, and wound healing. However, more bioavailability is needed to ensure its maximal therapeutic potential. Strategies to improve bioavailability include adjuvants like piperine, lipid formulations, structural analogs, and nanoparticulate delivery systems using natural and synthetic polymer-based carriers [51, 52]. These approaches enhance curcumin’s solubility, stability, and absorption to maximize its efficacy.

Nanoparticles of curcumin, also known as nano curcumin, have been extensively researched for improving bioavailability and therapeutic effects. Wet-milling, nanoprecipitation, and other techniques produce nano curcumin with reduced particle size and increased solubility. One study described wet-milled nano curcumin with a narrow size distribution [53], while another emphasized green manufacturing approaches to improve curcumin bioaccessibility [54]. Nanocurcumin formulations have improved efficacy and bioavailability in vivo, making them promising for cancer therapy [55]. Curcumin nanoparticles also have potential applications in dental implantology owing to their antibacterial properties against pathogens like Porphyromonas gingivalis, which commonly cause implant failure [56]. In conclusion, curcumin nanoparticles represent a promising means to enhance the therapeutic potential of curcumin through improved bioavailability and antimicrobial activity. Further research and clinical studies are essential to fully realize their potential while ensuring safety and efficacy for medical and dental uses.

Scaffold fabrication using the curcumin/graphene oxide/hydroxyapatite nanoparticles resulted in sustained curcumin release over a month. Analysis with osteoblast-like MG-63 cells revealed significant upregulation of osteogenic markers like osteopontin and bone sialoprotein compared to pure hydroxyapatite controls, confirming the critical role of released curcumin in driving differentiation [57].

4.4 Other plant-derived nanoparticles

In addition to the well-studied green tea extract, aloe vera-based, and curcumin nanoparticles, researchers have explored numerous lesser-known but promising plant-derived nanoparticles for stimulating bone regeneration. The diverse range of plant-derived nanoparticles presents a promising frontier in osteogenesis. Their unique properties, including bioactivity, biocompatibility, and biodegradability, make them suitable candidates for enhancing bone regeneration and treating bone-related diseases.

4.4.1 Grapefruit extract nanoparticles

Grapefruit extract contains naringin, a flavonoid with antioxidative and anti-inflammatory activities. Naringin nanoparticles promoted osteogenic differentiation of mesenchymal stem cells (MSCs) by upregulating bone morphogenetic protein-2 (BMP-2) and suppressing nuclear factor-kB (NF-kB) [58]. This photo-nanoparticle also increased alkaline phosphatase (ALP) activity, stimulated collagen production, and deposited calcium. Its ability to dually promote osteogenesis and inhibit osteoclastogenesis makes it a promising agent for restoring bone defects [59].

4.4.2 Licorice root nanoparticles

Licorice is a popular herbal medicine containing glabridin, which has estrogenic effects and helps manage postmenopausal osteoporosis. Glabridin nanoparticles enhanced viability and osteogenic differentiation in MSCs by stimulating estrogen receptor signaling [60]. It also inhibited hydrogen peroxide-induced cytotoxicity and reactive oxygen species production. As a phytoestrogen, glabridin is safer than traditional hormone replacement therapy for osteoporosis [61].

4.4.3 Flavonoid nanoparticles

Flavonoids, a diverse group of phytonutrients found in almost all fruits and vegetables, exhibit strong antioxidant properties. The encapsulation of flavonoids into nanoparticles has been explored to enhance their bioavailability and efficacy in osteogenesis [62]. For instance, when formulated into nanoparticles, quercetin, a well-known flavonoid, has significantly improved osteoblast proliferation and differentiation [63]. The enhanced solubility and stability of quercetin nanoparticles facilitate their uptake by bone cells, thereby stimulating the expression of osteogenic markers such as alkaline phosphatase (ALP), osteocalcin, and bone morphogenetic proteins (BMPs).

4.4.4 Silymarin nanoparticles

Silymarin, derived from the milk thistle plant (Silybum marianum), is another phytochemical with potent antioxidant and anti-inflammatory properties. Silymarin nanoparticles have been investigated for their potential in osteogenesis due to their ability to modulate bone metabolism [64]. Studies have demonstrated that silymarin nanoparticles can enhance osteoblasts’ proliferation and mineralization while inhibiting osteoclasts’ formation and activity. By balancing the activities of these cells, silymarin nanoparticles contribute to the maintenance and regeneration of bone tissue, making them a promising candidate for bone tissue engineering and the treatment of osteoporosis [65].

4.4.5 Ginseng nanoparticles

Ginseng, a traditional herbal medicine, contains bioactive compounds called ginsenosides, which have been implicated in various therapeutic effects, including osteogenesis. Ginsenoside-loaded nanoparticles have been designed to overcome the poor bioavailability of ginsenosides, enhancing their therapeutic potential in bone health [66]. These nanoparticles stimulate osteoblast differentiation and bone formation by activating the Wnt/β-catenin signaling pathway. Furthermore, ginseng nanoparticles have been shown to exert immunomodulatory effects, which can significantly benefit conditions characterized by inflammation-induced bone loss, such as osteoporosis and rheumatoid arthritis.

Advertisement

5. Mechanisms of action

Elucidating the mechanistic pathways involved in augmented osteogenic stimulation by phyto-nanoparticles remains an intense research pursuit. Uncovering these mechanisms at the biomolecular and cellular levels provides design feedback better to tailor nanoparticle properties for their intended modulatory roles. Central operating mechanisms encompass direct interactions of the nanoparticles with osteogenic cells to alter differentiation or activity, sustained intracellular delivery of cargo osteogenic drugs, and auxiliary anti-inflammatory and antimicrobial functionality.

The Table 1 summarizes the key processes through which each phyto-nanoparticle influences bone formation and remodeling. These mechanisms include the stimulation of osteoblast differentiation and mineralization, inhibiting osteoclast formation and activity, and modulation of signaling pathways involved in bone metabolism, such as Wnt/β-catenin, RANKL/OPG, BMP, and MAPK. The phyto-nanoparticles listed in the table are flavonoids, curcumin, resveratrol, quercetin, epigallocatechin gallate (EGCG), daidzein, and genistein. It is important to note that each phytonanoparticle may exert its effects through multiple cellular and molecular mechanisms, collectively contributing to the overall process of osteogenesis.

Phyto-nanoparticleMechanism of Action in Osteogenesis
Flavonoids
  • Stimulate osteoblast differentiation and mineralization

  • Inhibit osteoclast formation and activity

  • Enhance bone formation markers (e.g., alkaline phosphatase, collagen)

Curcumin
  • Promotes osteoblast differentiation and mineralization

  • Suppresses osteoclastogenesis and bone resorption

  • Modulates Wnt/β-catenin signaling pathway

Resveratrol
  • Enhances osteoblast differentiation and bone formation

  • Inhibits osteoclast differentiation and activity

  • Activates SIRT1 and AMPK signaling pathways

Quercetin
  • Stimulates osteoblast proliferation and differentiation

  • Inhibits osteoclast formation and bone resorption

  • Modulates RANKL/OPG ratio

Epigallocatechin gallate (EGCG)
  • Promotes osteoblast differentiation and mineralization

  • Suppresses osteoclast differentiation and activity

  • Regulates BMP and MAPK signaling pathways

Daidzein
  • Enhances osteoblast proliferation and differentiation

  • Inhibits osteoclastogenesis and bone resorption

  • Activates estrogen receptor signaling

Genistein
  • Stimulates osteoblast differentiation and bone formation

  • Suppresses osteoclast formation and activity

  • Modulates TGF-β/BMP and Wnt/β-catenin signaling pathways

Table 1.

Mechanisms of action of various Phyto-nanoparticles in osteogenesis.

5.1 Interaction with osteoblasts and osteoclasts

Plant nanoparticles have potential applications in bone remodeling, particularly on osteoblasts and osteoclasts. The studies suggest that the bioactive effects of nanoparticles on bone cells are size, surface property, and composition-dependent. For instance, silica nanoparticles have been demonstrated to improve bone mass and promote the differentiation of bone cells. Similarly, metallic nanoparticles are viable alternatives for bone repair and regeneration due to their bioactivity, biomimetic composition, and good incorporation within the natural bone structure [67]. Orchestrating the coordinated actions of bone-forming osteoblasts and resorbing osteoclasts is critical to developing mature mineralized tissues (Figure 3). Phyto-nanoparticles influence osteogenic outcomes through direct contact with these cells to modulate lineage commitment, differentiation, proliferation, adhesion, and matrix deposition. Particle internalization enables intracellular cargo delivery, while surface coatings present instructive cues to direct cell fate [68]. Nanotopography-mediated contact guidance is emerging as a powerful approach to control stem cell differentiation trajectories. Using green tea polyphenol nanoparticles, Luo et al. [69] described enhanced adhesion, spread, and proliferation in rat mesenchymal stem cells, which correlated with osteogenic marker expression. They postulated that the nanoparticle surfaces provided nanoscale cues resembling fibrillar bone extracellular matrix to promote osteoblastic phenotypes. Inorganic nanoparticles like hydroxyapatite similarly stimulated the fibroblastic differentiation of pre-osteoblastic MC3T3-E1 cells [70].

Figure 3.

Schematic representation of the cellular events occurring at the interface between a phyto-nanocoated implant and bone tissue during the healing process. The illustration depicts the key bone formation and remodeling stages, influenced by phyto-nanoparticles on the implant surface.

Iron oxide nanoparticles have been shown to promote osteoblast differentiation and inhibit osteoclast activity, suggesting a potential role in bone remodeling and regeneration [71]. Iron oxide nanoparticles can be synthesized using plant extracts, which offer a cost-effective, non-toxic, and environmentally friendly approach to obtaining nanoparticles. The biomolecules present in the plant extracts, such as phytochemicals, are responsible for the bioreduction and stabilization of the nanoparticles [72]. The studies suggest that metallic nanoparticles containing plant extracts have been used to treat bone disorders such as osteoporosis. The studies suggest that silver nanoparticles can inhibit differentiation into osteoclasts, indicating their potential as a treatment modality for bone-related diseases.

Besides morphology and adhesion changes, internalized phyto-nanoparticles can directly modulate intracellular signaling proteins and transcription cascades involved in differentiation. For instance, curcumin-gold nanoparticles were found to upregulate Ca2+/NFATc1 signaling through reactive oxygen species generation, consequently increasing alkaline phosphatase activity [73]. Resveratrol nanoparticles amplified miR-21 levels to suppress Smad-7 inhibitory effects on Runx2 and downstream effector activation leading to the commencement of osteoblastic gene expression programs [74]. In addition to osteoblastogenesis, a dynamic equilibrium between bone formation and resorption also necessitates the regulation of multinucleated osteoclasts from monocytic precursors. Undesirable excessive activity leads to net bone loss, compromising repair outcomes. As such, phyto-nanoparticles can target enhanced osteoblastogenesis with attenuated osteoclastogenesis [75]. Silica nanoparticles suppressed osteoclast differentiation and resorptive activity by downregulating NF-κB and interfering with RANK/RANKL signaling that initiates maturation. Meanwhile, hydroxyapatite nanoparticles mitigated reactive oxygen species propagation in osteoblasts subjected to oxidative challenge, preventing premature senescence and enabling sustained matrix deposition [76].

5.2 Drug delivery and sustained release

Plant nanoparticles are emerging as promising drug delivery systems and sustained-release vehicles because they can enhance therapeutic efficacy and mitigate side effects [77]. These nanoparticles, typically 10 to <1000 nm in size, can be engineered to encapsulate drugs and exhibit controlled release properties [78]. The physicochemical characteristics of nanoparticles, including size, surface area, surface chemistry, and shape, significantly impact their interactions within biological systems and are critical design parameters. For example, precise control over size and morphology is required to optimize performance and reduce toxicity. Furthermore, functionalizing the nanoparticle surface with polymers, antibodies, or other ligands facilitates active targeting of specific cells and tissues, thereby improving delivery capabilities [79].

Various nanoparticle platforms, such as lipid, polymer, and peptide nanoparticles, have been developed as drug delivery systems to transport therapeutic agents to intended sites within the body. These systems offer pharmacokinetic advantages compared to free drugs, enable targeting of specific cells, and mitigate off-target effects, thereby improving treatment efficacy [80]. The drug release kinetics can also be engineered by modifying nanoparticle size, surface traits, and composition to achieve sustained and controlled release profiles crucial for chronic therapies [81]. This targeted and sustained drug action reduces drug-induced toxicity while enhancing patient compliance through less frequent dosing regimens, ultimately translating to better patient outcomes. However, the clinical translation of plant nanoparticles warrants further research into the implications of their physicochemical attributes on biological interactions and the development of safe and efficacious drug delivery systems.

Phyto-nanoparticles act as versatile platforms for the intracellular delivery of osteogenic drugs to stimulate implanted scaffold cells or endogenous cells recruited to defect sites. Sustained release perpetuates bioactivity and enhances permeation throughout 3D-engineered tissues [82]. Nanoparticles facilitate passage through cell membranes for efficient internalization and residence within cytosol drug depots. Gradual diffusion or cumulative matrix erosion provides prolonged release kinetics that are optimal for maintaining cell stimulation without adverse effects from sudden bursts. Stimuli-responsive strategies using endogenous or exogenous triggers permit spatiotemporal control over release profiles [83]. Beyond growth factors, small molecule drugs have also been adapted into phyto-nanoparticles. Resveratrol-layered double hydroxide nanohybrids enabled tunable sustained release by diffusion control for over a month [84]. Rat calvarial defect treatment revealed up to 3-fold higher bone volumes than direct injection, confirming enhanced bioavailability and osteogenesis stimulation in vivo via the nanohybrid delivery system [85]. Curcumin nano-formulations similarly amplified therapeutic effects by increasing circulation half-life [86].

5.3 Anti-inflammatory and antimicrobial effects

Phyto-nanoparticles provide auxiliary anti-inflammatory and antimicrobial functionality alongside osteogenic stimulation effects to create optimal microenvironments facilitating repair [87]. Metabolically active compounds like polydatin and protocatechuic acid have been integrated into MSN mesoporous silica nanoparticles to dual-release anti-inflammatory osteogenic drugs [88]. Polydatin nanoparticles suppressed the secretion of inflammatory factors like TNF-α, IL-6, and nitric oxide in LPS-activated macrophages. The anti-inflammatory effects were further enhanced when co-delivered with bone morphogenetic protein two, stimulating mesenchymal stem cell recruitment and local regeneration. These synergistic combinations thus accelerate the resolution of inflammation to progress toward pro-osteogenic conditions [89]. Essential oils containing antimicrobial phytochemicals have been adapted onto osteoconductive bioceramic nanoparticles to combat bacterial infections [90]. Tea tree oil-functionalized magnesium phosphate nanoparticles provided a sustained release of antibacterial oil components alongside facilitating new bone growth [91]. The nanoparticles also induced minimal foreign body reaction and enhanced corrosion resistance compared to pure magnesium. These complementary osteogenic and antimicrobial properties will improve treatment outcomes for infected bone injuries [92].

Plant-mediated nanoparticles have significant anti-inflammatory and antimicrobial properties, making them promising candidates for biomedical applications. Specifically, silver and selenium nanoparticles synthesized using various plant extracts have shown potential as anti-inflammatory agents for treating conditions characterized by inflammation and antimicrobial agents for targeting resistant infections. Silver nanoparticles (AgNPs) synthesized using Aloe vera, green tea, grapefruit, Mentha piperita, and Catharanthus roseus extracts have exhibited anti-inflammatory capabilities [93, 94]. The anti-inflammatory effects make these AgNPs viable options for managing inflammatory ailments. Selenium nanoparticles (SeNPs) prepared using extracts of hawthorn fruit, onion, Thymus vulgaris, Ceropegia bulbosa Roxb, and Diospyros Montana have also demonstrated significant anti-inflammatory properties. These anti-inflammatory SeNPs hold promise as potential agents for treating inflammation-related diseases [95, 96]. Plant-mediated silver and selenium nanoparticles have also displayed broad-spectrum antimicrobial activity against various pathogenic bacteria and fungi. Their potent antimicrobial effects make these nanoparticles candidate alternatives to conventional antimicrobials for tackling drug-resistant infections. Plant-synthesized silver and selenium nanoparticles have shown considerable promise as anti-inflammatory agents for inflammatory diseases and antimicrobial agents for resistant infections [97]. Further research is warranted to translate these nanomaterials into clinical applications as anti-inflammatory and antimicrobial therapeutics.

Advertisement

6. Applications in bone regeneration

Capitalizing on their osteogenic stimulatory effects, phyto-nanoparticles have found widespread applications in designing advanced bone scaffolds, functionalizing orthopedic implants, and therapeutic carriers for bone disease treatments.

6.1 Scaffold materials for bone tissue engineering

Plant-derived nanoparticles are emerging as promising scaffold materials for bone tissue engineering owing to their biomimetic and osteoinductive properties. In particular, biocompatible silica nanoparticles from corn cob and rice husk stimulate osteoblast proliferation and bone growth while inhibiting osteoclasts, making them optimal scaffolds for bone disorders like osteoporosis [98, 99]. Beyond silica, calcium phosphate and gold nanoparticles also possess impressive osteogenic capabilities and have been studied as scaffolds for bone regeneration. For instance, strontium/magnesium-doped calcium phosphate nanoparticles have elicited positive in vitro responses from bone cells, underscoring their potential [100].

Capitalizing on the pro-osteogenic attributes, researchers have developed injectable hydrogels using composites of hydroxyapatite nanoparticles and plant derivatives like silk fibroin, cellulose, and chitosan [101]. Crosslinking chitosan-hydroxyapatite nanoparticles with aloe polysaccharides creates shear-thinning, self-recovery hydrogels suitable for minimally invasive delivery. The macroporous architecture enables bone marrow stem cell infiltration, proliferation, and osteogenic differentiation through controlled release of aloe bioactive phytochemicals, ultimately stimulating functional bone repair in vivo [102].

Plant nanocelluloses fabricated via acid hydrolysis of cellulose fibers also make highly porous bone scaffolds with mechanical integrity rivaling cancellous bones. The concomitant high-water retention facilitates nutrient diffusion and waste removal, enabling osteoblast migration and proliferation with early signs of matrix mineralization [103]. As the nanocelluloses degrade into non-toxic sugars, they mitigate long-term complications. Beyond direct bone formation, aloe polysaccharide nanoparticles delivering pro-angiogenic factors like VEGF from resident osteoblasts can also create vascularized grafts integrated with minimal fibrous scarring [46]. Such intelligently designed phyto-nanoparticles synchronize multiple mechanisms for synergistic bone regeneration.

6.2 Coatings for bone implants

Phyto-nanoparticles hold immense potential for surface modification of bone implants to enhance osseointegration. The current predominant use of bioinert metals like titanium often results in poor host tissue integration, provoking foreign body reactions, leading to fibrotic capsule formation, impairing implant-bone interlock, and providing infectious foci. Phyto-nanoparticle coatings present bioactive interfaces promoting bone cell migration and matrix deposition for accelerated anchorage [104]. Anti-inflammatory ingredients also mitigate immunogenic responses. Phyto-nanoparticle coatings aim to recapitulate multi-factorial extracellular niches by integrating osteoconductive, osteogenic, and anti-infective agents onto implant surfaces. For example, Sabir et al. fabricated zinc-doped hydroxyapatite silica coatings with clove extracts with innate antimicrobial properties. Sustained release of bioactive eugenol compounds inhibited adhesion and destroyed membranes of common pathogens, thus preventing implant-associated infections. The unimpeded growth of osteosarcoma cells also demonstrated excellent cytocompatibility [105].

Seeking dynamic interfaces, Motornov et al. [106] developed self-assembled films containing redox-responsive plant polyphenol nano-capsules on titanium dioxide nanotube arrays formed directly on titanium surfaces. The nano-capsules provided a controlled release of osteogenic and anti-inflammatory agents to stimulate endogenous cell activity. Redox triggers like hydrogen peroxide and ubiquitous glutathione unlocked cargo release by capsule swelling and membrane destabilization. Such innovative delivery systems enable spatiotemporal control, synchronizing therapeutic release profiles in tune with local biological cues [107].

Recent enthusiasm around graphene has sparked interest in phyto-mediated green synthesis of graphene-based implant coatings. Adding silver nanoparticles contributed to anti-infective effects against multidrug-resistant microbes. The accelerated hydroxyapatite deposition and alkaline phosphatase upregulation in osteoblasts cultured on these coatings demonstrated excellent biomineralization. Easy scalability makes such eco-friendly materials attractive for practical translational applications. Plant-derived nanoparticles can be used as coatings on dental and orthopedic implants to enhance their properties and performance. Zirconium nanoparticles from ginger and garlic have shown promise in enhancing dental implants’ antimicrobial, mechanical, and osseointegration properties [108]. Silver nanoparticles from Azadirachta indica (Neem), Aloe vera, Emblica Officinalis (Amla), Cinnamomum camphora extract, and curcumin nanoparticles from turmeric have antimicrobial effects to reduce infections [53, 109, 110, 111]. Zinc oxide nanoparticles from Camellia sinensis have low cytotoxicity and biocompatibility as dental implant coatings [112]. Plant extracts like Aloe vera, green tea, and grapefruit have synthesized gold nanoparticles to improve implant biocompatibility, mechanical properties, antimicrobial activity, and osteoinduction [113].

6.3 Targeted therapy for bone diseases

Bone disorders like osteoporosis and infectious osteomyelitis remain challenging clinical issues as conventional treatments struggle to stimulate regeneration and penetrate dense mineralized matrices. Phyto-nanoparticles present innovative solutions for targeted drug delivery to diseased skeletal sites by protecting cargo drugs from bodily clearance and providing sustained release. Their nanoscale size facilitates extravasation through porous vasculatures nourishing skeletal tissues. Concurrent multimodal imaging enables tracking to verify localization. Seeking osteo-targetability, Liang et al. [114] prepared calcium-deficient hydroxyapatite nanoparticles with high binding affinity to the bone matrix. Covalent tethering of the anti-osteoporotic bisphosphonate alendronate further augmented hydroxyapatite specificity for skeleton tissues. Phyto-sourced berberine alkaloids with anti-osteoporotic effects were then loaded into the nanoparticles. Selective in vivo depot within bone enabled sustained berberine release, stimulating osteoblast differentiation while ameliorating ovariectomy-induced bone loss [112]. Such targeted delivery maximizes therapeutic indexes at diseased sites while avoiding systemic exposure.

Contending with osteomyelitis, Alegrete et al. [115] devised starch-based nanocarriers for bone-selective delivery of vancomycin antibiotics. Cationic surface coatings enabled electrostatic loading of anionic vancomycin molecules with 85% efficiency. Sustained vancomycin release inhibited bacterial growth for a week, reducing inflammatory TNF-alpha and osteoclast activity. Osteoblast proliferation also recovered. Effective infection control coupled with mitigated bone damage illustrates the merits of phyto-nanoparticles for therapeutic delivery, combining innate bioactivity and biocompatibility [113]. In summary, these regenerative medicine niches spanning tissue engineering, implant modification, and drug delivery vehicles provide promising clinical translation pathways capitalizing on emergent phyto-nanotechnology research. A common theme is the recognition of how multifaceted extracellular milieu factors synergistically direct tissue healing outcomes. Appropriately designed phyto-nanoparticles offer intelligently engineered tools integrating biological and physical inputs to stimulate endogenous regenerative responses.

Advertisement

7. Future perspectives and conclusions

Phyto-nanotechnology remains in its early stages, with further innovations in fabrication strategies and biomedical applications necessary to fully tap this vast, untapped potential. Ongoing adoption of personalized medicine approaches appears highly feasible. Additionally, hybrid platforms synergistically combining plant nanoparticles with complementary nanostructures and technologies could engender augmented therapeutic capacities exceeding individual components. In summary, these promising directions forecast next-generation phyto-nanosystems dramatically advancing bone regenerative capabilities and transforming clinical practice. Research fusing plant-based nanomaterials with technologies like 3D bioprinting and externally triggered smart nanoparticles could enable customized patient therapies and enhanced control over healing outcomes. Further research and development focusing on efficacy, safety, and clinical integration will be vital to realizing the full clinical potential of these powerful emerging approaches.

7.1 Innovations in synthesis and application

In recent years, the integration and use of plant-sourced nanoparticles in medicine and dentistry have gained considerable interest. Adopting plant extracts to generate nanoparticles provides multiple benefits over traditional approaches, including cost-effectiveness, environmental sustainability, and control over nanoparticle structure. This method also overcomes nanoparticle clustering during formation, enabling the production of diverse nanoparticle types. Plant-based nanoparticles have shown promise in improving dental implants’ compatibility, durability, and antibacterial properties. Creating bone-targeted nanoparticles and carriers from plants also holds the potential for enhancing osteoporosis treatment by improving drug delivery, minimizing side effects, and boosting the efficacy and safety of osteoporosis medications. The future outlook of plant nanoparticles is promising, with ongoing research on developing new synthesis techniques, characterization methods, and applications. Plant nanoparticles offer advantages over conventional physicochemical preparations, including cost-effectiveness, eco-friendliness, morphology control, and the ability to prevent nanoparticle agglomeration during production for a wide range of nanoparticles.

7.2 Integration with other nanotechnologies

Integrating plant-sourced nanoparticles with other nanostructures, materials, and technologies shows immense potential for synergistic platforms that enhance efficacy beyond individual components. Hybrid nanocomposites combining cellulose, silk, or chitosan phyto-nanoparticles with osteoconductive hydroxyapatites or bioactive glasses can produce scaffolds that mimic complementary aspects of native bone extracellular matrix. This could provide more biomimetic environments to guide bone formation. Incorporating magnetic and plasmonic metal nanoparticles within phyto-nanoparticle matrices could enable external manipulation and stimulation using alternating magnetic fields and laser irradiation. This may allow spatiotemporal control over scaffold activities to better direct cell differentiation and healing. Imaging techniques like surface-enhanced Raman spectroscopy using phyto-reduced gold nanorods also facilitate deeper tracking of bone regeneration in vivo, which is crucial for evaluating translation potential.

Bridging niche applications, fluoride-releasing phyto-nanoparticles could have concurrent antibacterial effects against cariogenic pathogens responsible for dental caries and infections that endanger orthopedic implants. Phyto-nanosystems may also help mitigate bone loss side effects of anticancer medications. Beyond passive carriers, cell membrane-coated phyto-nanoparticles cloaked with blood cell or stem cell membranes may enable biomimetic vehicles for immune system evasion and enhanced tissue penetration. These multifunctional capacities gained from hybridization with emerging nanotechnologies promise innovative solutions for enhanced bone repair. In summary, further research at the intersection of plant biosciences and nanotechnology can realize smarter phyto-nanomaterials designed to synchronize the complex extracellular signals that collectively coordinate optimal healing. Seamless integration into clinical practice promises transformative positive impacts on restoring skeletal function for countless worldwide suffering from bone diseases or injuries.

7.3 Potential in personalized medicine

Inter-patient variability and unique defect microenvironments contribute to inconsistent outcomes using standardized treatments. Transitioning toward personalized medicine paradigms that tailor therapies to individual needs could address these inconsistencies. Readily functionalized phyto-nanoparticles with tunable properties present versatile platforms that enable patient-specific formulations. Nuclear imaging and magnetic relaxation switching may non-invasively track nanoparticle pharmacokinetics and localization within distinct wound sites. This facilitates identifying disease subsets most responsive to particular formulations. Omics profiling discerns proteomic biomarkers and implicated genetic polymorphisms guiding formulation optimization, including specific phytochemical agents targeting dysregulated pathways. Patient-derived cells could determine optimal scaffolded cargo combinations (e.g., cells, genes, drugs) for improved engraftment. 3D bioprinting also enables designing custom macro-architecture and internal porous features adapted to scanned defect volumes. On-demand activation of smart phyto-nanomaterials with external triggers (ultrasound, electromagnetic fields) further permits unprecedented spatiotemporal control over particular cellular stimulation events. These could be programmed in response to personalized healing events like inflammation resolution or cell mobilization waves. Such dynamic, personalized therapies will ultimately improve the consistency and quality of treatment outcomes.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine. Molecules. 2019;25:1-15. Epub 20191227. DOI: 10.3390/molecules25010112
  2. 2. Malik S, Muhammad K, Waheed Y. Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023;28:1-30. Epub 20230914. DOI: 10.3390/molecules28186624
  3. 3. Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: Recent advances and challenges. Critical Reviews in Biomedical Engineering. 2012;40:363-408. DOI: 10.1615/critrevbiomedeng.v40.i5.10
  4. 4. Hong MH, Lee JH, Jung HS, Shin H, Shin H. Biomineralization of bone tissue: Calcium phosphate-based inorganics in collagen fibrillar organic matrices. Biomaterials Research. 2022;26:42. Epub 20220906. DOI: 10.1186/s40824-022-00288-0
  5. 5. Jiang S, Wang M, He J. A review of biomimetic scaffolds for bone regeneration: Toward a cell-free strategy. Bioengineering & Translational Medicine. 2021;6:e10206. Epub 20201215. DOI: 10.1002/btm2.10206
  6. 6. Hasan A, Morshed M, Memic A, Hassan S, Webster TJ, Marei HE. Nanoparticles in tissue engineering: Applications, challenges and prospects. International Journal of Nanomedicine. 2018;13:5637-5655. Epub 20180924. DOI: 10.2147/IJN.S153758
  7. 7. Mahmoud NS, Ahmed HH, Mohamed MR, Amr KS, Aglan HA, Ali MAM, et al. Role of nanoparticles in osteogenic differentiation of bone marrow mesenchymal stem cells. Cytotechnology. 2020;72:1-22. Epub 20191113. DOI: 10.1007/s10616-019-00353-y
  8. 8. Udomluck N, Koh WG, Lim DJ, Park H. Recent developments in nanofiber fabrication and modification for bone tissue engineering. International Journal of Molecular Sciences. 2019;21:1-16. Epub 20191221. DOI: 10.3390/ijms21010099
  9. 9. Hano C, Abbasi BH. Plant-based green synthesis of nanoparticles: Production, characterization and applications. Biomolecules. 2021;12:1-9. Epub 20211225. DOI: 10.3390/biom12010031
  10. 10. Lee J, Park EY, Lee J. Non-toxic nanoparticles from phytochemicals: Preparation and biomedical application. Bioprocess and Biosystems Engineering. 2014;37:983-989. Epub 20131122 10.1007/s00449-013-1091-3
  11. 11. Husen A, Siddiqi KS. Phytosynthesis of nanoparticles: Concept, controversy and application. Nanoscale Research Letters. 2014;9:229. Epub 20140512. DOI: 10.1186/1556-276X-9-229
  12. 12. Jadhav K, Hr R, Deshpande S, Jagwani S, Dhamecha D, Jalalpure S, et al. Phytosynthesis of gold nanoparticles: Characterization, biocompatibility, and evaluation of its osteoinductive potential for application in implant dentistry. Materials Science & Engineering. C, Materials for Biological Applications. 2018;93:664-670. Epub 20180810. DOI: 10.1016/j.msec.2018.08.028
  13. 13. Tiwari S, Verma SK, Bhagat P, Yadav S, Sharma R, Aseri GK, et al. An overview of the phytosynthesis of various metal nanoparticles. 3 Biotech. 2021;11:478. Epub 20211029. DOI: 10.1007/s13205-021-03014-0
  14. 14. Yao Q , Yuan X, Fung V, Yu Y, Leong DT, Jiang DE, et al. Understanding seed-mediated growth of gold nanoclusters at molecular level. Nature Communications. 2017;8:927. Epub 20171013. DOI: 10.1038/s41467-017-00970-1
  15. 15. Ashraf H, Anjum T, Riaz S, Naseem S. Microwave-assisted green synthesis and characterization of silver nanoparticles using Melia azedarach for the management of fusarium wilt in tomato. Frontiers in Microbiology. 2020;11:238. Epub 20200310. DOI: 10.3389/fmicb.2020.00238
  16. 16. Gao L, Mei S, Ma H, Chen X. Ultrasound-assisted green synthesis of gold nanoparticles using citrus peel extract and their enhanced anti-inflammatory activity. Ultrasonics Sonochemistry. 2022;83:105940. Epub 20220203. DOI: 10.1016/j.ultsonch.2022.105940
  17. 17. Bhilkar PR, Bodhne AS, Yerpude ST, Madankar RS, Somkuwar SR, Daddemal-Chaudhary AR, et al. Phyto-derived metal nanoparticles: Prominent tool for biomedical applications. OpenNano. 2023;14:100192. DOI: 10.1016/j.onano.2023.100192
  18. 18. Puri A, Patil S, Mulik M. Biomedical applications of biogenic phytonanoparticles a review. International Journal of Botany. 2021;6:534-540
  19. 19. Thatyana M, Dube NP, Kemboi D, Manicum AE, Mokgalaka-Fleischmann NS, Tembu JV. Advances in phytonanotechnology: A plant-mediated green synthesis of metal nanoparticles using phyllanthus plant extracts and their antimicrobial and anticancer applications. Nanomaterials (Basel). 2023;13:1-30. Epub 20230922. DOI: 10.3390/nano13192616
  20. 20. Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as drug delivery systems: A review of the implication of nanoparticles' physicochemical properties on responses in biological systems. Polymers (Basel). 2023;15:1-26. Epub 20230323. DOI: 10.3390/polym15071596
  21. 21. Hafez, Ghoran S, Calcaterra A, Abbasi M, Taktaz F, Nieselt K, Babaei E. Curcumin-based nanoformulations: A promising adjuvant towards cancer treatment. Molecules. 2022;27:1-29. Epub 20220816. DOI: 10.3390/molecules27165236
  22. 22. Kazemi S, Hosseingholian A, Gohari SD, Feirahi F, Moammeri F, Mesbahian G, et al. Recent advances in green synthesized nanoparticles: From production to application. Materials Today Sustainability. 2023;24:100500. DOI: 10.1016/j.mtsust.2023.100500
  23. 23. Hajialyani M, Tewari D, Sobarzo-Sánchez E, Nabavi SM, Farzaei MH, Abdollahi M. Natural product-based nanomedicines for wound healing purposes: Therapeutic targets and drug delivery systems. International Journal of Nanomedicine. 2018;13:5023-5043. Epub 20180903. DOI: 10.2147/ijn.S174072
  24. 24. Abuzeid HM, Julien CM, Zhu L, Hashem AM. Green synthesis of nanoparticles and their energy storage. Environmental, and Biomedical Applications Crystals. 2023;13:1576. DOI: 10.3390/cryst13111576
  25. 25. Adeyemi JO, Oriola AO, Onwudiwe DC, Oyedeji AO. Plant extracts mediated metal-based nanoparticles: Synthesis and biological applications. Biomolecules. 2022;12:1-28. Epub 20220424. DOI: 10.3390/biom12050627
  26. 26. Mehan S, Arora N, Bhalla S, Khan A, Rehman MU, Alghamdi BS, et al. Involvement of phytochemical-encapsulated nanoparticles' interaction with cellular signalling in the amelioration of benign and malignant brain tumours. Molecules. 2022;27:1-27. Epub 20220601. DOI: 10.3390/molecules27113561
  27. 27. Vohra K, Dureja H, Garg V, Dutt R. Current trends in phyto-cancer therapy using nanoparticles current. Nanomedicine. 2019;9:30-45. DOI: 10.2174/2468187308666180613102448
  28. 28. Singh H, Desimone MF, Pandya S, Jasani S, George N, Adnan M, et al. Revisiting the green synthesis of nanoparticles: Uncovering influences of plant extracts as reducing agents for enhanced synthesis efficiency and its biomedical applications. International Journal of Nanomedicine. 2023;18:4727-4750. Epub 20230818. DOI: 10.2147/ijn.S419369
  29. 29. Osman AI, Zhang Y, Farghali M, Rashwan AK, Eltaweil AS, Abd El-Monaem EM, et al. Synthesis of green nanoparticles for energy, biomedical, environmental, agricultural, and food applications: A review. Environmental Chemistry Letters. 2024;22:841-887. DOI: 10.1007/s10311-023-01682-3
  30. 30. Sharma R, Sharma N, Prashar A, Hansa A, Asgari Lajayer B, Price GW. Unraveling the plethora of toxicological implications of nanoparticles on living organisms and recent insights into different remediation strategies: A comprehensive review. Science of the Total Environment. 2024;906:167697. DOI: 10.1016/j.scitotenv.2023.167697
  31. 31. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9:e17488. Epub 20230624. DOI: 10.1016/j.heliyon.2023.e17488
  32. 32. Mohammadinejad R, Karimi S, Iravani S, Varma RS. Plant-derived nanostructures: Types and applications. Green Chemistry. 2016;18:20-52. DOI: 10.1039/c5gc01403d
  33. 33. Gopal J, Muthu M, Paul D, Kim DH, Chun S. Bactericidal activity of green tea extracts: The importance of catechin containing nano particles. Scientific Reports. 2016;6:19710. Epub 20160128. DOI: 10.1038/srep19710
  34. 34. Polito CA, Cai ZY, Shi YL, Li XM, Yang R, Shi M, et al. Association of tea consumption with risk of Alzheimer's disease and anti-beta-amyloid effects of tea. Nutrients. 2018;10:1-18. Epub 20180522. DOI: 10.3390/nu10050655
  35. 35. Kim HM, Kim J. The effects of green tea on obesity and type 2 diabetes. Diabetes & Metabolism Journal. 2013;37:173-175. DOI: 10.4093/dmj.2013.37.3.173
  36. 36. Ninsiima HI, Eze ED, Ssekatawa K, Nalugo H, Asekenye C, Onanyang D, et al. Green tea silver nanoparticles improve physiological motor and cognitive function in BALB/c mice during inflammation. Heliyon. 2023;9:e13922. Epub 20230221. DOI: 10.1016/j.heliyon.2023.e13922
  37. 37. Lin SY, Kan JY, Lu CC, Huang HH, Cheng TL, Huang HT, et al. Green tea catechin (−)-epigallocatechin-3-gallate (EGCG) facilitates fracture healing. Biomolecules. 2020;10:1-10. Epub 20200416. DOI: 10.3390/biom10040620
  38. 38. Shen CL, Yeh JK, Cao JJ, Wang JS. Green tea and bone metabolism. Nutrition Research. 2009;29:437-456. DOI: 10.1016/j.nutres.2009.06.008
  39. 39. Chu C, Deng J, Man Y, Qu Y. Green tea extracts epigallocatechin-3-gallate for different treatments. BioMed Research International. 2017;2017:5615647. Epub 20170813. DOI: 10.1155/2017/5615647
  40. 40. Zhang X, He J, Qiao L, Wang Z, Zheng Q , Xiong C, et al. 3D printed PCLA scaffold with nano-hydroxyapatite coating doped green tea EGCG promotes bone growth and inhibits multidrug-resistant bacteria colonization. Cell Proliferation. 2022;55:e13289. Epub 20220705. DOI: 10.1111/cpr.13289
  41. 41. Huang HT, Cheng TL, Lin SY, Ho CJ, Chyu JY, Yang RS, et al. Osteoprotective roles of green tea catechins. Antioxidants (Basel). 2020;9:1136. Epub 20201116. DOI: 10.3390/antiox9111136
  42. 42. Sanchez M, Gonzalez-Burgos E, Iglesias I, Gomez-Serranillos MP. Pharmacological update properties of aloe vera and its major active constituents. Molecules. 2020;25:1-37. Epub 20200313. DOI: 10.3390/molecules25061324
  43. 43. Pradeep AR, Garg V, Raju A, Singh P. Adjunctive local delivery of aloe vera gel in patients with type 2 diabetes and chronic periodontitis: A randomized, controlled clinical trial. Journal of Periodontology. 2016;87:268-274. Epub 20151008. DOI: 10.1902/jop.2015.150161
  44. 44. Alinejad-Mofrad S, Foadoddini M, Saadatjoo SA, Shayesteh M. Improvement of glucose and lipid profile status with aloe vera in pre-diabetic subjects: A randomized controlled-trial. Journal of Diabetes and Metabolic Disorders. 2015;14:22. Epub 20150409. DOI: 10.1186/s40200-015-0137-2
  45. 45. Teplicki E, Ma Q , Castillo DE, Zarei M, Hustad AP, Chen J, et al. The effects of aloe vera on wound healing in cell proliferation, migration, and viability. Wounds. 2018;30:263-268
  46. 46. Yao XW, Liu HD, Ren MX, Li TL, Jiang WK, Zhou Z, et al. Aloe polysaccharide promotes osteogenesis potential of adipose-derived stromal cells via BMP-2/Smads and prevents ovariectomized-induced osteoporosis. Molecular Biology Reports. 2022;49:11913-11924. Epub 20221015. DOI: 10.1007/s11033-022-08003-x
  47. 47. Banerjee D, Bose S. Effects of aloe vera gel extract in doped hydroxyapatite-coated titanium implants on in vivo and in vitro biological properties. ACS Applied Bio Materials. 2019;2:3194-3202. Epub 20190719. DOI: 10.1021/acsabm.9b00077
  48. 48. Ghorbani M, Nezhad-Mokhtari P, Ramazani S. Aloe vera-loaded nanofibrous scaffold based on zein/polycaprolactone/collagen for wound healing. International Journal of Biological Macromolecules. 2020;153:921-930. Epub 20200306. DOI: 10.1016/j.ijbiomac.2020.03.036
  49. 49. Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Research and Treatment. 2014;46:2-18. Epub 20140115. DOI: 10.4143/crt.2014.46.1.2
  50. 50. Ma Z, Wang N, He H, Tang X. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. Journal of Controlled Release. 2019;316:359-380. Epub 20191102. DOI: 10.1016/j.jconrel.2019.10.053
  51. 51. Srinivasan K. Black pepper and its pungent principle-piperine: A review of diverse physiological effects. Critical Reviews in Food Science and Nutrition. 2007;47:735-748. DOI: 10.1080/10408390601062054
  52. 52. Punfa W, Yodkeeree S, Pitchakarn P, Ampasavate C, Limtrakul P. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Acta Pharmacologica Sinica. 2012;33:823-831. Epub 20120514. DOI: 10.1038/aps.2012.34
  53. 53. Bhawana I, Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. Journal of Agricultural and Food Chemistry. 2011. Epub 20110215;59:2056-2061. DOI: 10.1021/jf104402t
  54. 54. Ubeyitogullari A, Ciftci ON. A novel and green nanoparticle formation approach to forming low-crystallinity curcumin nanoparticles to improve curcumin's bioaccessibility. Scientific Reports. 2019;9:19112. Epub 20191213. DOI: 10.1038/s41598-019-55619-4
  55. 55. Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi OR. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna Journal of Phytomedicine. 2016;6:383-398
  56. 56. Maleki Dizaj S, Shokrgozar H, Yazdani J, Memar MY, Sharifi S, Ghavimi MA. Antibacterial effects of curcumin nanocrystals against porphyromonas gingivalis isolated from patients with implant failure. Clinics and Practice. 2022;12:809-817. Epub 20221006. DOI: 10.3390/clinpract12050085
  57. 57. Al-Ani LA, Kadir FA, Hashim NM, Julkapli NM, Seyfoddin A, Lu J, et al. The impact of curcumin-graphene based nanoformulation on cellular interaction and redox-activated apoptosis: An in vitro colon cancer study. Heliyon. 2020;6:e05360. Epub 20201102. DOI: 10.1016/j.heliyon.2020.e05360
  58. 58. Gan J, Deng X, Le Y, Lai J, Liao X. The development of naringin for use against bone and cartilage disorders. Molecules. 2023;28:1-20. Epub 20230425. DOI: 10.3390/molecules28093716
  59. 59. Fan J, Li J, Fan Q. Naringin promotes differentiation of bone marrow stem cells into osteoblasts by upregulating the expression levels of microRNA-20a and downregulating the expression levels of PPARgamma. Molecular Medicine Reports. 2015;12:4759-4765. Epub 20150624. DOI: 10.3892/mmr.2015.3996
  60. 60. Heo JS, Lee SG, Kim HO. The flavonoid glabridin induces OCT4 to enhance osteogenetic potential in mesenchymal stem cells. Stem Cells International. 2017;2017:6921703. Epub 20171114. DOI: 10.1155/2017/6921703
  61. 61. Al-Anazi AF, Qureshi VF, Javaid K, Qureshi S. Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overview. Journal of Natural Science, Biology, and Medicine. 2011;2:154-163. DOI: 10.4103/0976-9668.92322
  62. 62. Yang J, Zhang L, Ding Q , Zhang S, Sun S, Liu W, et al. Flavonoid-loaded biomaterials in bone defect repair. Molecules. 2023;28:6888. Epub 20230930. DOI: 10.3390/molecules28196888
  63. 63. Wong SK, Chin KY, Ima-Nirwana S. Quercetin as an agent for protecting the bone: A review of the current evidence. International Journal of Molecular Sciences. 2020;21:1-37. Epub 20200903. DOI: 10.3390/ijms21176448
  64. 64. Szwed-Georgiou A, Plocinski P, Kupikowska-Stobba B, Urbaniak MM, Rusek-Wala P, Szustakiewicz K, et al. Bioactive materials for bone regeneration: Biomolecules and delivery systems. ACS Biomaterials Science & Engineering. 2023;9:5222-5254. Epub 20230816. DOI: 10.1021/acsbiomaterials.3c00609
  65. 65. Kim JL, Park SH, Jeong D, Nam JS, Kang YH. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice. Experimental Biology and Medicine (Maywood, N.J.). 2012;237:417-428. Epub 20120410. DOI: 10.1258/ebm.2011.011376
  66. 66. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, et al. Pharmacological potential of ginseng and its major component ginsenosides. Journal of Ginseng Research. 2021;45:199-210. Epub 20200325. DOI: 10.1016/j.jgr.2020.02.004
  67. 67. Gupta A, Mehta SK, Kumar A, Singh S. Advent of phytobiologics and nano-interventions for bone remodeling: A comprehensive review. Critical Reviews in Biotechnology. 2023;43:142-169. Epub 20211226. DOI: 10.1080/07388551.2021.2010031
  68. 68. Gao W, Liang C, Zhao K, Hou M, Wen Y. Multifunctional gold nanoparticles for osteoporosis: Synthesis, mechanism and therapeutic applications. Journal of Translational Medicine. 2023;21:889. Epub 20231207. DOI: 10.1186/s12967-023-04594-6
  69. 69. Luo J, Walker M, Xiao Y, Donnelly H, Dalby MJ, Salmeron-Sanchez M. The influence of nanotopography on cell behaviour through interactions with the extracellular matrix - A review. Bioactive Materials. 2022;15:145-159. Epub 20211221. DOI: 10.1016/j.bioactmat.2021.11.024
  70. 70. Wutticharoenmongkol P, Pavasant P, Supaphol P. Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles. Biomacromolecules. 2007;8:2602-2610. Epub 20070727. DOI: 10.1021/bm700451p
  71. 71. Marycz K, Sobierajska P, Roecken M, Kornicka-Garbowska K, Kepska M, Idczak R, et al. Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action. Journal of Nanobiotechnology. 2020;18:33. Epub 20200218. DOI: 10.1186/s12951-020-00590-w
  72. 72. Saif S, Tahir A, Chen Y. Green synthesis of iron nanoparticles and their environmental applications and implications. Nanomaterials (Basel). 2016;6:1-26. Epub 20161112. DOI: 10.3390/nano6110209
  73. 73. Chopra H, Dey PS, Das D, Bhattacharya T, Shah M, Mubin S, et al. Curcumin nanoparticles as promising therapeutic agents for drug targets. Molecules. 2021;26:1-28. Epub 20210818. DOI: 10.3390/molecules26164998
  74. 74. Wang J, He F, Chen L, Li Q , Jin S, Zheng H, et al. Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways. Biomedicine & Pharmacotherapy. 2018;105:37-44. Epub 20180526. DOI: 10.1016/j.biopha.2018.05.104
  75. 75. Liu K, Wang Z, Liu J, Zhao W, Qiao F, He Q , et al. Atsttrin regulates osteoblastogenesis and osteoclastogenesis through the TNFR pathway. Communications Biology. 2023;6:1251. Epub 20231211. DOI: 10.1038/s42003-023-05635-y
  76. 76. Yin Z, Gong G, Liu X, Yin J. Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis. Frontiers in Immunology. 2023;14:1274679. Epub 20231004. DOI: 10.3389/fimmu.2023.1274679
  77. 77. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology. 2018;16:71. Epub 20180919. DOI: 10.1186/s12951-018-0392-8
  78. 78. Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: Emerging carriers for drug delivery. Saudi Pharmaceutical Journal. 2011;19:129-141. Epub 20110421. DOI: 10.1016/j.jsps.2011.04.001
  79. 79. Yagublu V, Karimova A, Hajibabazadeh J, Reissfelder C, Muradov M, Bellucci S, et al. Overview of physicochemical properties of nanoparticles as drug carriers for targeted cancer therapy. Journal of Functional Biomaterials. 2022;13:1-11. Epub 20221020. DOI: 10.3390/jfb13040196
  80. 80. Sarvarian P, Samadi P, Gholipour E, Shams Asenjan K, Hojjat-Farsangi M, Motavalli R, et al. Application of emerging plant-derived nanoparticles as a novel approach for nano-drug delivery systems. Immunological Investigations. 2022;51:1039-1059. Epub 20210225. DOI: 10.1080/08820139.2021.1891094
  81. 81. Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal. 2018;26:64-70. Epub 20171025. DOI: 10.1016/j.jsps.2017.10.012
  82. 82. Wen J, Cai D, Gao W, He R, Li Y, Zhou Y, et al. Osteoimmunomodulatory nanoparticles for bone regeneration. Nanomaterials (Basel). 2023;13:1-21. Epub 20230210. DOI: 10.3390/nano13040692
  83. 83. Wen J, Li H, Dai H, Hua S, Long X, Li H, et al. Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. Materials Today Bio. 2023;19:100597. Epub 20230226. DOI: 10.1016/j.mtbio.2023.100597
  84. 84. Herrera-Arozamena C, Estrada-Valencia M, Lopez-Caballero P, Perez C, Morales-Garcia JA, Perez-Castillo A, et al. Resveratrol-based MTDLs to stimulate defensive and regenerative pathways and block early events in neurodegenerative cascades. Journal of Medicinal Chemistry. 2022;65:4727-4751. Epub 20220304. DOI: 10.1021/acs.jmedchem.1c01883
  85. 85. Stephan SJ, Tholpady SS, Gross B, Petrie-Aronin CE, Botchway EA, Nair LS, et al. Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope. 2010;120:895-901. DOI: 10.1002/lary.20624
  86. 86. Tagde P, Tagde P, Islam F, Tagde S, Shah M, Hussain ZD, et al. The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders. Molecules. 2021;26:1-33. Epub 20211124. DOI: 10.3390/molecules26237109
  87. 87. Nandhini SN, Sisubalan N, Vijayan A, Karthikeyan C, Gnanaraj M, Gideon DAM, et al. Recent advances in green synthesized nanoparticles for bactericidal and wound healing applications. Heliyon. 2023;9:e13128. Epub 20230121. DOI: 10.1016/j.heliyon.2023.e13128
  88. 88. Sandomierski M, Chojnacka M, Dlugosz M, Pokora M, Zwolinska J, Majchrzycki L, et al. Mesoporous silica modified with polydopamine and zinc ions as a potential carrier in the controlled release of mercaptopurine. Materials (Basel). 2023;16:1-16. Epub 20230613. DOI: 10.3390/ma16124358
  89. 89. Li W, Xiang Z, Yu W, Huang X, Jiang Q , Abumansour A, et al. Natural compounds and mesenchymal stem cells: Implications for inflammatory-impaired tissue regeneration. Stem Cell Research & Therapy. 2024;15:34. Epub 20240207. DOI: 10.1186/s13287-024-03641-3
  90. 90. Ghosh S, Nandi S, Basu T. Nano-antibacterials using medicinal plant components: An overview. Frontiers in Microbiology. 2021;12:768739. Epub 20220222. DOI: 10.3389/fmicb.2021.768739
  91. 91. Manzanelli FA, Ravetti S, Brignone SG, Garro AG, Martinez SR, Vallejo MG, et al. Enhancing the functional properties of tea tree oil: In vitro antimicrobial activity and microencapsulation strategy. Pharmaceutics. 2023;15:1-17. Epub 20231019. DOI: 10.3390/pharmaceutics15102489
  92. 92. Zhong X, Gao F, Wei H, Zhou H, Zhou X. Functionalization of mesoporous silica as an effective composite carrier for essential oils with improved sustained release behavior and long-term antibacterial performance. Nanotechnology. 2021;33:035706. Epub 20211029. DOI: 10.1088/1361-6528/ac2fe2
  93. 93. Mustapha T, Misni N, Ithnin NR, Daskum AM, Unyah NZ. A review on plants and microorganisms mediated synthesis of silver nanoparticles, role of plants metabolites and applications. International Journal of Environmental Research and Public Health. 2022;19:1-17. Epub 20220107. DOI: 10.3390/ijerph19020674
  94. 94. Ahmed S, Ahmad M, Swami BL, Ikram S. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. Journal of Advanced Research. 2016;7:17-28. Epub 20150309. DOI: 10.1016/j.jare.2015.02.007
  95. 95. Pyrzynska K, Sentkowska A. Biosynthesis of selenium nanoparticles using plant extracts. Journal of Nanostructure in Chemistry. 2021;12:467-480. DOI: 10.1007/s40097-021-00435-4
  96. 96. Pandiyan I, Sri SD, Indiran MA, Rathinavelu PK, Prabakar J, Rajeshkumar S. Antioxidant, anti-inflammatory activity of Thymus vulgaris-mediated selenium nanoparticles: An in vitro study. Journal of Conservative Dentistry. 2022;25:241-245. Epub 20220613. DOI: 10.4103/JCD.JCD_369_21
  97. 97. Sans-Serramitjana E, Obreque M, Munoz F, Zaror C, Mora ML, Vinas M, et al. Antimicrobial activity of selenium nanoparticles (SeNPs) against potentially pathogenic oral microorganisms: A scoping review. Pharmaceutics. 2023;15:1-22. Epub 20230831. DOI: 10.3390/pharmaceutics15092253
  98. 98. Ha SW, Viggeswarapu M, Habib MM, Beck GR Jr. Bioactive effects of silica nanoparticles on bone cells are size, surface, and composition dependent. Acta Biomaterialia. 2018;82:184-196. Epub 20181014. DOI: 10.1016/j.actbio.2018.10.018
  99. 99. Jugdaohsingh R, Calomme MR, Robinson K, Nielsen F, Anderson SH, D'Haese P, et al. Increased longitudinal growth in rats on a silicon-depleted diet. Bone. 2008;43:596-606. Epub 20080502. DOI: 10.1016/j.bone.2008.04.014
  100. 100. Kostka K, Hosseini S, Epple M. In-vitro cell response to strontium/magnesium-doped calcium phosphate nanoparticles. Micro. 2023;3:156-171. DOI: 10.3390/micro3010012
  101. 101. Omidian H, Chowdhury SD. Advancements and applications of injectable hydrogel composites in biomedical research and therapy. Gels. 2023;9:533. Epub 20230630. DOI: 10.3390/gels9070533
  102. 102. Zhu Y, Wang Y, Jia Y, Xu J, Chai Y. Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt/beta-catenin pathway. Stem Cell Research & Therapy. 2019;10:37. Epub 20190122. DOI: 10.1186/s13287-019-1143-y
  103. 103. Poulose A, Parameswaranpillai J, George JJ, Gopi JA, Krishnasamy S, Dominic CDM, et al. Nanocellulose: A fundamental material for science and technology applications. Molecules. 2022;27:1-27. Epub 20221119. DOI: 10.3390/molecules27228032
  104. 104. Hossain N, Mobarak MH, Hossain A, Khan F, Mim JJ, Chowdhury MA. Advances of plant and biomass extracted zirconium nanoparticles in dental implant application. Heliyon. 2023;9:e15973. Epub 20230506. DOI: 10.1016/j.heliyon.2023.e15973
  105. 105. Chowdhury MA, Hossain N, Mostofa MG, Mia MR, Tushar M, Rana MM, et al. Green synthesis and characterization of zirconium nanoparticlefor dental implant applications. Heliyon. 2023;9:e12711. Epub 20221230. DOI: 10.1016/j.heliyon.2022.e12711
  106. 106. Motornov M, Malynych SZ, Pippalla DS, Zdyrko B, Royter H, Roiter Y, et al. Field-directed self-assembly with locking nanoparticles. Nano Letters. 2012;12:3814-3820. Epub 20120625. DOI: 10.1021/nl301780x
  107. 107. Shankar SS, Rai A, Ahmad A, Sastry M. Rapid synthesis of Au, Ag, and bimetallic Au core-Ag shell nanoparticles using neem (Azadirachta indica) leaf broth. Journal of Colloid and Interface Science. 2004;275:496-502. DOI: 10.1016/j.jcis.2004.03.003
  108. 108. Ankamwar B, Damle C, Ahmad A, Sastry M. Biosynthesis of gold and silver nanoparticles using Emblica Officinalis fruit extract, their phase transfer and transmetallation in an organic solution. Journal of Nanoscience and Nanotechnology. 2005;5:1665-1671. DOI: 10.1166/jnn.2005.184
  109. 109. Li W, Qu F, Chen Y, Sun Y, Zhang J, Xie G, et al. Antimicrobial activity of sliver nanoparticles synthesized by the leaf extract of Cinnamomum camphora. Biochemical Engineering Journal. 2021;172:108050. DOI: 10.1016/j.bej.2021.108050
  110. 110. Nava OJ, Luque PA, Gómez-Gutiérrez CM, Vilchis-Nestor AR, Castro-Beltrán A, Mota-González ML, et al. Influence of Camellia sinensis extract on zinc oxide nanoparticle green synthesis. Journal of Molecular Structure. 2017;1134:121-125. DOI: 10.1016/j.molstruc.2016.12.069
  111. 111. Sirelkhatim A, Mahmud S, Seeni A, Kaus NHM, Ann LC, Bakhori SKM, et al. Review on zinc oxide nanoparticles: Antibacterial activity and toxicity mechanism. Nano-micro Letters. 2015;7:219-242. Epub 20150419. DOI: 10.1007/s40820-015-0040-x
  112. 112. Dayanandan AP, Cho WJ, Kang H, Bello AB, Kim BJ, Arai Y, et al. Emerging nano-scale delivery systems for the treatment of osteoporosis. Biomaterials Research. 2023;27:68. Epub 20230713. DOI: 10.1186/s40824-023-00413-7
  113. 113. Cheng H, Chawla A, Yang Y, Li Y, Zhang J, Jang HL, et al. Development of nanomaterials for bone-targeted drug delivery. Drug Discovery Today. 2017;22:1336-1350. Epub 20170506. DOI: 10.1016/j.drudis.2017.04.021
  114. 114. Liang W, Ding P, Li G, Lu E, Zhao Z. Hydroxyapatite nanoparticles facilitate osteoblast differentiation and bone formation within sagittal suture during expansion in rats. Drug Design, Development and Therapy. 2021;15:905-917. Epub 20210301. DOI: 10.2147/DDDT.S299641
  115. 115. Alegrete N, Sousa SR, Padrao T, Carvalho A, Lucas R, Canadas RF, et al. Vancomycin-loaded, nanohydroxyapatite-based scaffold for osteomyelitis treatment: In vivo rabbit toxicological tests and In vivo efficacy tests in a sheep model. Bioengineering (Basel). 2023;10:1-19. Epub 20230204. DOI: 10.3390/bioengineering10020206

Written By

Nandita Suresh, Betsy Joseph, Tuomas Waltimo and Sukumaran Anil

Submitted: 04 March 2024 Reviewed: 05 March 2024 Published: 20 June 2024